Standardize and Harmonize Product Information with Fonto: Advancing the ePI Initiative

In the ever-evolving landscape of pharmaceutical regulations and information management, the need to standardize and harmonize product information has become increasingly crucial. At the forefront of this movement is the Swedish Medical Products Agency, Läkemedelsverket, which has recently made significant strides with their ePI (electronic Product Information) Proof of Concept. In this post, we’re sharing …

Standardize and Harmonize Product Information with Fonto: Advancing the ePI Initiative Read More »

Update on national pilot study for pharmaceutical companies creating ePI

In 2022, the Swedish Medical Products Agency (Swedish MPA) selected Fonto as the editor of choice for the creation of electronic structured SmPC’s. Over the past few months, the Swedish MPA has developed an XML template adapted for Fonto. Electronic product information In a Proof-of-Concept model, information elements are divided into categories depending on the …

Update on national pilot study for pharmaceutical companies creating ePI Read More »

Swedish Medical Products Agency selects Fonto

Hurra! Fonto has been selected as the XML editor of choice by the Swedish Medical Products Agency (Swedish MPA) for a national pilot study for pharmaceutical companies creating ePI.  Electronic Product Information (ePI) ePI refers to the authorized, statutory product information for medicines (including the Summary of Product Characteristics, Package leaflet and labelling) adapted for …

Swedish Medical Products Agency selects Fonto Read More »

Structured content for pharma

It takes pharma companies about five times longer to create content, compared to other industries. Delayed drug approvals turn into an average loss of $1 million dollars per day for pharma companies. Val Swisher and Regina Lynn Preciado from Content Rules recently published an interesting e-book: “Structured Content for Pharma – Making the Case for …

Structured content for pharma Read More »

Moving from Word: why changing the interface is unacceptable

In pharma—and many other industries, too—Microsoft Word is the tool to create content. It’s the natural environment for many subject-matter experts to write, edit and review content. Every author is familiar with the Word interface. But it’s not structured content that’s created … “We cannot change the authoring experience” Forcing subject-matter experts, for example medical …

Moving from Word: why changing the interface is unacceptable Read More »

Scroll to Top